40
https://pubmed.ncbi.nlm.nih.gov/38114390
This study is a case series examining central nervous system disease progression in metastatic urothelial carcinoma patients treated with enfortumab vedotin, with authors from the University of California San Francisco disclosing various conflicts of interest.